More importantly, amplification of TGF‐β gene is the most frequent type of mutation associated with breast invasive carcinoma (Figure 1B), which is in keeping with the fact that TGF‐β is a strong inducer of EMT.21 This evidence concerns the gene TGFB1 and invasive breast carcinoma.